The pharmaceutical industry is growing at a rapid pace with a significant surge in healthcare expenditure worldwide due to the rising geriatric population and increasing prevalence of chronic illnesses. Also, consistent research and development (R&D) efforts and rapid technological advancements boost the industry’s prospects.
Given the industry’s promising outlook, it could be wise to buy quality pharma stocks Collegium Pharmaceutical, Inc. (COLL), Eton Pharmaceuticals, Inc. (ETON), and GSK plc (GSK) in December for solid gains.
